Cordyceps sinensis protects against renal ischemia/reperfusion injury in rats
- PMID: 23184050
- DOI: 10.1007/s11033-012-2316-2
Cordyceps sinensis protects against renal ischemia/reperfusion injury in rats
Abstract
Cordyceps sinensis (CS) is an entomogenous fungus used as a tonic food and Chinese medicine to replenish health. This study investigated the protective effects of CS in rats post-renal ischemia-reperfusion (I/R) sequence by analyzing the influence on stromal cell-derived factor-1α (SDF-1α and chemokine (C-X-C motif) receptor 4 (CXCR4) expressions and senescence during recovery. Chemokine SDF-1 [now called chemokine C-X-C motif ligand 12 (CXCL12)] and its receptor CXCR4 are crucial in kidney repair after ischemic acute renal failure. CS treatment significantly alleviated I/R-induced renal damage assessed by creatinine levels (p < 0.05) and abated renal tubular damages assessed by periodic acid-Schiff with diastase (PASD) staining. CS induced early SDF-1α expression and increased CXCR4 expression 1-6 h post-reperfusion. Histology studies have revealed that CS induced SDF-1α in squamous cells of Bowman's capsule, mesangial cells, distal convoluted tubules (DCT), and proximal convoluted tubules (PCT). CS also improved renal repair in I/R-induced injury by increasing Ki-67 staining. I/R induced renal senescence after 3 and 6 h of reperfusion. However, CS alleviated I/R-induced senescence at early stage (1 and 3 h). We conclude that CS protects against I/R injury via the SDF-1/CXCR4-signaling axis and alleviates senescence.
Similar articles
-
[Effect of Cordyceps sinensis on the expression of HIF-1α and NGAL in rats with renal ischemia-reperfusion injury].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;37(1):57-66. doi: 10.3969/j.issn.1672-7347.2012.01.011. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22349381 Chinese.
-
The Function of SDF-1-CXCR4 Axis in SP Cells-Mediated Protective Role for Renal Ischemia/Reperfusion Injury by SHH/GLI1-ABCG2 Pathway.Shock. 2017 Feb;47(2):251-259. doi: 10.1097/SHK.0000000000000694. Shock. 2017. PMID: 27454381
-
Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.Eur J Pharmacol. 2019 Oct 15;861:172620. doi: 10.1016/j.ejphar.2019.172620. Epub 2019 Aug 19. Eur J Pharmacol. 2019. PMID: 31437429
-
CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.Am J Physiol Gastrointest Liver Physiol. 2015 Apr 15;308(8):G702-9. doi: 10.1152/ajpgi.00257.2014. Epub 2015 Feb 26. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 25721302 Free PMC article.
-
Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review.Front Pharmacol. 2022 May 13;13:881835. doi: 10.3389/fphar.2022.881835. eCollection 2022. Front Pharmacol. 2022. PMID: 35645822 Free PMC article. Review.
Cited by
-
Therapeutic effect of Corbrin (Bailing) capsule on patients with renal insufficiency: A meta-analysis.Heliyon. 2024 Apr 10;10(8):e29488. doi: 10.1016/j.heliyon.2024.e29488. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38699752 Free PMC article.
-
Correlations of SDF-1ɑ and XRCC1 gene polymorphisms with the risk of renal cancer development and bioinformatics studies of SDF-1α and XRCC1 and the prognosis of renal cancer.Sci Rep. 2024 Feb 9;14(1):3367. doi: 10.1038/s41598-024-53808-4. Sci Rep. 2024. PMID: 38337001 Free PMC article.
-
Protective Mechanism of Cordyceps sinensis Treatment on Acute Kidney Injury-Induced Acute Lung Injury through AMPK/mTOR Signaling Pathway.Chin J Integr Med. 2023 Oct;29(10):875-884. doi: 10.1007/s11655-023-3593-4. Epub 2023 Feb 27. Chin J Integr Med. 2023. PMID: 36843056
-
Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis.J Diabetes Res. 2021 Sep 28;2021:5477941. doi: 10.1155/2021/5477941. eCollection 2021. J Diabetes Res. 2021. PMID: 34621904 Free PMC article.
-
Renal-Protective Effects and Potential Mechanisms of Traditional Chinese Medicine after Ischemia-Reperfusion Injury.Evid Based Complement Alternat Med. 2021 Feb 19;2021:5579327. doi: 10.1155/2021/5579327. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33680054 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
